Serina Therapeutics Inc
(SER)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 56 | 3,153 | 34 | 144 | 361 |
| Cost of Goods | N/A | N/A | 13 | 19 | 26 |
| Gross Profit | 56 | 3,153 | 21 | 125 | 335 |
| Operating Expenses | 17,104 | 6,282 | 7,009 | 8,077 | 10,461 |
| Operating Income | -17,048 | -3,129 | -6,975 | -7,933 | -10,100 |
| Interest Expense | 526 | 558 | 3,335 | 1,097 | 404 |
| Other Income | 6,367 | 8,956 | -212 | 448 | -622 |
| Pre-tax Income | -11,207 | 5,269 | -10,522 | -8,582 | -11,126 |
| Income Tax | 0 | 0 | N/A | N/A | -150 |
| Net Income Continuous | -11,207 | 5,269 | -10,522 | -8,582 | -10,976 |
| Net Income Discontinuous | N/A | N/A | N/A | -103 | N/A |
| Minority Interests | -66 | N/A | -60 | -10 | -111 |
| Net Income | $-11,141 | $5,269 | $-10,462 | $-8,675 | $-10,865 |
| EPS Basic Total Ops | -1.51 | 2.36 | -9.70 | -8.10 | -10.21 |
| EPS Basic Continuous Ops | -1.52 | 2.36 | -9.75 | -7.98 | -9.86 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | -0.10 | -0.35 |
| EPS Diluted Total Ops | -1.51 | 0.73 | -9.70 | -8.10 | -10.21 |
| EPS Diluted Continuous Ops | -1.52 | 0.72 | -9.75 | -7.98 | -9.86 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | -0.10 | -0.35 |
| EPS Diluted Before Non-Recurring Items | -1.51 | -13.72 | -9.86 | -8.10 | -10.21 |
| EBITDA(a) | $-16,509 | $-3,039 | $-3,706 | $-6,688 | $-8,358 |